MUC1 and triple-negative breast carcinoma: Several researchers have also isolated specific antibodies against the extracellular structure of MUC1-C that recognize recombinant MUC1 and the native MUC1-C protein in breast cancer cells and screened for antibodies that highly inhibit the invasion of triple-negative breast cancers.